Y.J. Ko

404 total citations
17 papers, 268 citations indexed

About

Y.J. Ko is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Y.J. Ko has authored 17 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Y.J. Ko's work include Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). Y.J. Ko is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Treatment and Pharmacology (3 papers). Y.J. Ko collaborates with scholars based in Canada, United States and South Korea. Y.J. Ko's co-authors include Kelvin Chan, Vincent C. Tam, Nicole Mittmann, Matthew C. Cheung, Axel Glasmacher, Casimir Funk, J. Mezger, Tilman Sauerbruch, Andrew J. Smith and Hans T. Chung and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and European Journal of Surgical Oncology.

In The Last Decade

Y.J. Ko

16 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y.J. Ko Canada	9	173	115	105	54	37	17	268
Maurizio Leoni Italy	11	168 1.0×	43 0.4×	95 0.9×	31 0.6×	23 0.6×	21	290
Nisha L. Jacobs United States	6	201 1.2×	51 0.4×	77 0.7×	57 1.1×	9 0.2×	10	279
Richard M. Lee‐Ying Canada	10	168 1.0×	78 0.7×	125 1.2×	71 1.3×	15 0.4×	49	299
J Lokich United States	6	342 2.0×	87 0.8×	98 0.9×	55 1.0×	11 0.3×	7	414
Carmela Caballero Belgium	10	164 0.9×	95 0.8×	140 1.3×	25 0.5×	17 0.5×	33	357
Francine Fein France	11	195 1.1×	154 1.3×	130 1.2×	33 0.6×	7 0.2×	26	336
Suprith Badarinath United States	9	270 1.6×	49 0.4×	118 1.1×	59 1.1×	7 0.2×	16	309
Dayssy A. Diaz United States	12	151 0.9×	118 1.0×	114 1.1×	45 0.8×	23 0.6×	47	388
Danielle Benedict Sacdalan Philippines	8	264 1.5×	50 0.4×	96 0.9×	8 0.1×	20 0.5×	26	350
H.A. Phillips United Kingdom	10	228 1.3×	158 1.4×	107 1.0×	7 0.1×	25 0.7×	16	396

Countries citing papers authored by Y.J. Ko

Since Specialization

Citations

This map shows the geographic impact of Y.J. Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y.J. Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y.J. Ko more than expected).

Fields of papers citing papers by Y.J. Ko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y.J. Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y.J. Ko. The network helps show where Y.J. Ko may publish in the future.

Co-authorship network of co-authors of Y.J. Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Y.J. Ko. A scholar is included among the top collaborators of Y.J. Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y.J. Ko. Y.J. Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ko, Y.J., Jung Hyun Jo, Si Young Song, & Hee Seung Lee. (2025). The crucial role of CEMIP in cancer metastasis: Mechanistic insights and clinical implications. The FASEB Journal. 39(1). e70284–e70284. 4 indexed citations

Kim, Kwang Joon, et al.. (2025). Using Large Language Models to Simulate History Taking: Implications for Symptom-Based Medical Education. Information. 16(8). 653–653.

Chan, Kelvin, et al.. (2020). A Systematic Review and Network Meta-Analysis of Adjuvant Therapy for Curatively Resected Biliary Tract Cancers. Current Oncology. 27(1). 20–26. 6 indexed citations

Ko, Y.J., et al.. (2020). A Systematic Review and Network Meta-Analysis of Second-Line Therapy in Hepatocellular Carcinoma. Current Oncology. 27(6). 300–306. 7 indexed citations

Parmar, Ambica, Kelvin Chan, & Y.J. Ko. (2019). Metastatic Colorectal Cancer: Therapeutic Options for Treating Refractory Disease. Current Oncology. 26(11). 24–32. 13 indexed citations

Ko, Y.J., Mahmoud Abdelsalam, Petr Kavan, et al.. (2019). What Is a Clinically Meaningful Survival Benefit in Refractory Metastatic Colorectal Cancer?. Current Oncology. 26(2). 255–259. 5 indexed citations

Elser, Christine, et al.. (2018). Oncology Education for Canadian Internal Medicine Residents: The Value of Participating in a Medical Oncology Elective Rotation. Current Oncology. 25(3). 213–218. 4 indexed citations

Chan, Kelvin, et al.. (2017). A Systematic Review and Network Meta-Analysis of Post-Imatinib Therapy in Advanced Gastrointestinal Stromal Tumour. Current Oncology. 24(6). 531–539. 8 indexed citations

Lien, Kelly, Vincent C. Tam, Y.J. Ko, et al.. (2015). Impact of Country-Specific EQ-5D-3L Tariffs on the Economic Value of Systemic Therapies Used in the Treatment of Metastatic Pancreatic Cancer. Current Oncology. 22(6). 443–452. 21 indexed citations

10.

Pond, Gregory R., Joaquim Bellmunt, Jonathan E. Rosenberg, et al.. (2014). Impact of the Number of Prior Lines of Therapy and Prior Perioperative Chemotherapy in Patients Receiving Salvage Therapy for Advanced Urothelial Carcinoma: Implications for Trial Design. Clinical Genitourinary Cancer. 13(1). 71–79. 11 indexed citations

11.

Tam, Vincent C., et al.. (2013). Cost-Effectiveness of Systemic Therapies for Metastatic Pancreatic Cancer. Current Oncology. 20(2). 90–106. 59 indexed citations

12.

Karanicolas, Paul J., Peter Metrakos, Kelvin Chan, et al.. (2013). Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement. Current Oncology. 21(1). 129–129. 44 indexed citations

13.

Cukier, Moisés, Andrew J. Smith, Laurent Milot, et al.. (2012). Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: A single institution experience. European Journal of Surgical Oncology. 38(8). 677–682. 45 indexed citations

14.

Harris, Kristin, Edward Chow, Emily Sinclair, et al.. (2007). New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada. Current Oncology. 14(1). 9–12. 8 indexed citations

15.

Ko, Y.J., Scott R. Berry, D. Scott Ernst, et al.. (2006). Dose escalation phase of a phase I/II study of GTI-2501, an antisense to the R1 subunit of ribonucleotide reductase (RNR) and docetaxel in patients with metastatic hormone-refractory prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 2078–2078. 3 indexed citations

16.

Byrnes, Christine, et al.. (2004). A randomized phase II study of thalidomide with or without erythropoietin (EPO) in metastatic renal cell carcinoma (RCC). Journal of Clinical Oncology. 22(14_suppl). 4747–4747. 2 indexed citations

17.

Mezger, J., et al.. (1998). Phase II Study with Gemcitabine in Gallbladder and Biliary Tract Carcinomas<sub>a</sub>. Oncology Research and Treatment. 21(3). 232–234. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact